newsfilter
← Latest News
ClinicalTrials.gov·

Study to Investigate the Pharmacokinetics, Pharmacodynamics and Assess the Efficacy and Safety to Support Dose Selection of Emapalumab in Pre-empting Graft Failure in Patients at High Risk After HSCT. - NCT04731298

Serum concentrations of free emapalumab, Serum concentration of free and total Interferon gamma (IFNγ), Serum concentration of C-X-C Motif Chemokine Ligand 9 (CXCL9), (and 69 more...)